Key clinical point: A new supercooling process could extend ex vivo liver viability by more than a day, which could help relieve the organ donor–shortage crisis.
Major finding: Supercooling extended liver viability by 27 hours.
Study details: An ex vivo study testing viability of supercooled human livers for transplantation.
Disclosures: The study was funded by the National Institutes of Health and the Department of Defense. Five coauthors reported provisional patent applications related to the study, and one coauthor disclosed a financial relationship with Organ Solutions.
de Vries RJ et al. Nature Biotechnol. 2019 Sep 9..